Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
FDA tentatively hints at EUA, with a trial requirement, for Veru's new Covid drug ahead of adcomm
3 years ago
FDA+
Coronavirus
ONO exercises Fate CAR-T option in latest twist to partners' four-year deal
3 years ago
Pharma
Cell/Gene Tx
Astellas signals oncology aspirations to healthcare providers in ‘Changemakers’ campaign
3 years ago
Pharma
Marketing
Merck continues rare breast cancer campaign focused on challenges for Black women
3 years ago
Pharma
Marketing
For $700M+, Viatris nabs two biotechs as eye disease emphasis comes into view
3 years ago
Deals
With all hands on deck for lead sickle cell trial, Beam pulls back clinical plans for second base editing therapy
3 years ago
R&D
Cell/Gene Tx
Sensorion nabs rare pediatric designation for gene therapy; Avalo sells off remaining drug rights for $5M
3 years ago
News Briefing
Kura Oncology secures up to $150M in Bristol Myers equity investment, loan from Hercules Capital
3 years ago
Financing
As Roche prepares to take a kidney disease drug into PhIII, Ionis fleshes out the data
3 years ago
R&D
Updated: Verve's landmark base editing trial for cardio drug runs into FDA hold
3 years ago
R&D
Cell/Gene Tx
GSK reports PhIII flop for BCMA drug — raising questions about its future and upping the stakes on combos
3 years ago
R&D
Amgen maps a PhIII journey for its latest great cardio drug hopeful. Can it succeed this time?
3 years ago
R&D
Latest news on patient death in n-of-1 CRISPR trial; Good news for RSV; Vaccine R&D revolution; and more
3 years ago
Weekly
Updated: Flagship sends a vet — post-Rubius implosion — into the breach at Repertoire
3 years ago
People
Insmed, Alnylam and others make Science's list of top 20 biopharma employers
3 years ago
Pharma
Marketing
N-of-1 CRISPR trial ends with a death as nonprofit digs into what happened
3 years ago
Cell/Gene Tx
Teva reaches $523M agreement with New York in latest opioid-related settlement
3 years ago
Pharma
Law
Performer Teyana Taylor joins Joe Jonas in helping Merz 'ring the alarm' on frown lines
3 years ago
Marketing
Novo Nordisk plots commercial relaunch for Wegovy as supplies are expected to return
3 years ago
Pharma
Marketing
Santhera lays out options in bid for commercialization funds; Swiss biotech’s Covid work narrows
3 years ago
News Briefing
FDA delays decision for Apellis' eye disease drug after biotech submits updated data
3 years ago
R&D
FDA+
Three years after underwhelming data, Lieping Chen's NextCure drops lead program
3 years ago
R&D
Avanir files WARN notice for 100+ layoffs from California as merger with parent Otsuka looms
3 years ago
People
'Rulebook of microbial ecology': Pianists launch Concerto to treat eczema, protect crops and get rid of BO
3 years ago
Financing
Startups
First page
Previous page
427
428
429
430
431
432
433
Next page
Last page